Health officials and drug companies have been grappling for years over how to define what constitutes a “cancer drug” and what constitutes “advanced medical instruments” that could be used to treat the disease.
And now the Centers for Disease Control and Prevention has come up with a new definition that could help the companies determine which drugs should be approved.
The agency is calling the new definition advanced medical devices, and it will be included in a draft of the next version of the National Drug Strategy.
This will be the final version of which the drug companies will be able to approve drugs for use.
The definition will be a guideline for manufacturers to follow, said the CDC director, Dr. Andrew Kolodny.
He said it will likely be used by drug companies to determine which types of advanced medical equipment they should be allowed to make.
The draft version of what the FDA will consider to be a “drug” includes all of the components of the drug, including a cure, an anti-tumor agent, an immunotherapeutic agent and a treatment for a disease, such as cancer.
The CDC defines advanced medical technology as drugs and medical devices that are made by pharmaceutical companies and used to manufacture drugs for a patient’s disease or condition, or are otherwise developed to be used in a medical procedure.
The new definition is based on the U.S. government’s National Center for Injury Prevention and Control, which defines advanced technology as anything that is made by a company or medical device company to be delivered to the patient, according to a draft version that was obtained by The Washington Times.
The National Center defines advanced therapy as drugs made by companies that use advanced medical technologies to treat a disease.
It also includes medical devices and medical equipment that are used to perform surgery and to treat conditions that are not diseases, including conditions that cause only mild symptoms, such in mild pain.
The FDA is currently evaluating the potential of adding a new category to its existing definition of “advances in technology” to encompass advanced medical therapy.
The government is working on revisions of the definition of advanced medicine and has not yet made a final decision.
The final version is expected to be released in March or April.
It will also likely be adopted by the National Academies of Sciences, Engineering, and Medicine, the U,S.
Congress and the U